(Q74295223)
Statements
Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse (English)
de Haas V
Breunis WB
Verhagen OJ
van der Berg H
van der Schoot CE